{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:21:49Z","timestamp":1794871309641,"version":"4.9.1"},"reference-count":37,"publisher":"Frontiers Media SA","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1477,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1432-2277.2011.01312.x","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T15:15:49Z","timestamp":1313507749000},"page":"1084-1093","source":"Crossref","is-referenced-by-count":87,"title":["Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules"],"prefix":"10.3389","volume":"24","author":[{"given":"Irma-Sofia A.","family":"Ntokou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki G.","family":"Iniotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet N.","family":"Kontou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N.","family":"Darema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Apostolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkibiadis G.","family":"Kostakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Boletis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2011,8,16]]},"reference":[{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB1|cit1","volume-title":"Clinical Transplants","author":"Cecka","year":"1995"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB2|cit2","volume-title":"Clinical Transplants","author":"Kaneku","year":"2006"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007890-198902000-00018","article-title":"Posttransplant antibodies and graft rejection: evaluation by two-color flow cytometry","volume":"47","author":"Scornick","year":"1989","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/00007890-200104270-00017","article-title":"Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometry techniques","volume":"71","author":"Piazza","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: \u03b1 prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1399-0039.2005.00382.x","article-title":"Anti-HLA class II antibodies in kidney retransplant patients","volume":"65","author":"\u0391rnold","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-200210270-00025","article-title":"All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies","volume":"74","author":"Lee","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.TP.0000055833.65192.3B","article-title":"Post-transplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome","volume":"75","author":"Worthington","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.humimm.2005.07.005","article-title":"HLA antibody identification with single antigen beads compared to conventional methods","volume":"66","author":"El-Awar","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31820794bb","article-title":"Interpretation of positive flow cytometric crossmatch in the era of the single antigen bead assay","volume":"91","author":"Couzi","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2002.00425.x","article-title":"Immune responsiveness in renal transplant recipients: Mycophenolic acid severelly depresses humoral immunity in vivo","volume":"62","author":"Rentenaar","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007890-200002150-00001","article-title":"Anti-HLA antibodies after solid organ transplantation","volume":"69","author":"McKena","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.tp.0000174338.97313.5a","article-title":"Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2- year prospective trial","volume":"80","author":"Terasaki","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-6143.2002.020204.x","article-title":"Cinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation","volume":"2","author":"Pelletier","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure","volume":"6","author":"Campos","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/pgmj.47.544.89","article-title":"Presensitization and kidney transplant failure","volume":"47","author":"Terasaki","year":"1971","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB17|cit17","first-page":"3737","article-title":"Kidney transplantation in sensitized patients","volume":"19","author":"Opelz","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.humimm.2009.04.013","article-title":"Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Sudy report","volume":"70","author":"Susal","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ki.1996.460","article-title":"The humoral immune response towards HLA class II determinants in renal transplantation","volume":"50","author":"Feucht","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/00007890-199806150-00024","article-title":"HLA class I and class II antibodies","volume":"65","author":"Schonemann","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/j.1600-6143.2009.02836.x","article-title":"The impact of C4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/01.tp.0000261108.27421.bc","article-title":"Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility","volume":"83","author":"Doxiadis","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.1998.tb01224.x","article-title":"Intramolecular and intermolecular spreading during the course of organ allograft rejection","volume":"164","author":"Suciu-Foca","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/01.TP.0000061611.51612.09","article-title":"Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplant period","volume":"75","author":"Iniotaki-Theodoraki","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.humimm.2005.07.002","article-title":"Expansion of humoral donor-specific alloreactivity after renal transplantation correlates with impaired graft outcome","volume":"66","author":"Varnabidou-Nicolaidou","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/TP.0b013e3181804cd2","article-title":"Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients","volume":"86","author":"Deng","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0041-1345(00)02094-7","article-title":"Immune reactivity towards HLA class II determinants in renal transplantation","volume":"33","author":"Iniotaki-Theodoraki","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA - specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.humimm.2005.01.021","article-title":"Humoral theory of transplantation: mechanisms, prevention and treatment","volume":"66","author":"Cai","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2215\/CJN.00270106","article-title":"Mechanisms and role of HLA and non-HLA alloantibodies","volume":"1","author":"Tincman","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.TP.0000155246.52249.AC","article-title":"Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction","volume":"79","author":"Zhang","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.coi.2010.08.009","article-title":"Non-MHC antigenic targets of the humoral immune response in transplantation","volume":"22","author":"Zhang","year":"2010","journal-title":"Cur Opin Immunol"},{"key":"10.1111\/j.1432-2277.2011.01312.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1600-6143.2006.01560.x","article-title":"Development of non-donor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens","volume":"6","author":"Cai","year":"2006","journal-title":"Am J Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2011.01312.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2011.01312.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:37:14Z","timestamp":1641062234000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2011.01312.x"}},"subtitle":["Post-transplant anti-HLA alloantibodies in renal transplantation"],"short-title":[],"issued":{"date-parts":[[2011,8,16]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01312.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,16]]}}}